What is the likely diagnosis and recommended management for a patient whose estimated glomerular filtration rate dropped from 106 mL/min/1.73 m² to 85 mL/min/1.73 m², then to 69 mL/min/1.73 m², and subsequently recovered to 90 mL/min/1.73 m², with a transient serum potassium of 3.1 mmol/L that later normalized?

Acute Kidney Injury (AKI) with Transient Hypokalemia - Likely Diagnosis and Management

This clinical presentation is most consistent with acute kidney injury (AKI) that has resolved, likely precipitated by hypovolemia or a transient prerenal insult, with the hypokalemia serving as both a clue to the underlying cause and potentially a contributing factor.

Diagnostic Classification

The pattern described meets criteria for AKI based on the functional decline, followed by recovery. According to established definitions, AKI is characterized by an increase in serum creatinine ≥0.3 mg/dL within 48 hours OR ≥50% increase within 7 days 1, 2. Your patient's eGFR dropped from 106 to 69 mL/min/1.73 m² (approximately 35% decline), which translates to a significant creatinine rise that would meet AKI criteria.

The subsequent recovery to eGFR 90 mL/min/1.73 m² within two weeks indicates this was acute kidney disease (AKD) rather than chronic kidney disease, as the dysfunction lasted less than 3 months and showed functional recovery 3.

Most Likely Etiology

The concurrent hypokalemia (3.1 mmol/L) provides critical diagnostic information:

• Hypokalemia-induced AKI: Low potassium can cause renal vasoconstriction and reduced GFR through multiple mechanisms
• Volume depletion: The combination of declining GFR with hypokalemia strongly suggests prerenal azotemia from volume loss (vomiting, diarrhea, diuretic use, inadequate intake)
• Medication-related: Diuretics are the most common cause of this combined presentation

The rapid recovery after potassium normalization and the two-week timeframe for GFR improvement support a reversible prerenal or functional cause rather than intrinsic kidney damage 1, 4.

Key Diagnostic Considerations

Factors favoring reversible AKI (as seen here):

• Rapid decline in eGFR over days to weeks
• Associated electrolyte abnormality (hypokalemia)
• Complete or near-complete recovery within 2-4 weeks
• No evidence of proteinuria mentioned (would suggest intrinsic disease) 5

What this is NOT:

• Chronic kidney disease: Would require ≥3 months duration and typically shows slower, progressive decline 6, 7
• Acute tubular necrosis: Would show slower recovery (weeks to months)
• Rapidly progressive glomerulonephritis: Would have persistent proteinuria/hematuria and incomplete recovery

Recommended Management Approach

Immediate Assessment (if presenting acutely):

1. Identify and address precipitants:

   • Review all medications, especially diuretics, ACE inhibitors, ARBs, NSAIDs
   • Assess volume status clinically (orthostatic vitals, mucous membranes, skin turgor)
   • Check for ongoing losses (GI, renal)

2. Laboratory evaluation:

   • Repeat serum creatinine and potassium to confirm stability
   • Urinalysis with microscopy to exclude intrinsic kidney disease
   • Urine albumin-to-creatinine ratio (UACR) - if elevated, suggests underlying kidney damage 4, 8
   • Complete metabolic panel including calcium, phosphate, bicarbonate

3. Medication review:

   • Temporarily discontinue nephrotoxic agents (NSAIDs)
   • Adjust doses of renally cleared medications based on nadir GFR
   • If on ACE inhibitors/ARBs: Small creatinine increases up to 30% are acceptable and protective long-term, but this degree of decline warrants temporary hold 4, 9

Ongoing Monitoring Strategy:

For patients with resolved AKI returning to eGFR ≥60 mL/min/1.73 m²:

• Recheck eGFR and potassium in 1-2 weeks to confirm stability
• Then monitor every 3-6 months for the first year (AKI increases future CKD risk) 4, 8
• Annual monitoring thereafter if stable 10

Critical monitoring thresholds 1, 4:

• Worsening renal function = creatinine increase ≥0.3 mg/dL OR eGFR decline >20%
• Significant decline = eGFR drop >5 mL/min/1.73 m²/year
• Either threshold warrants nephrology referral

When to Refer to Nephrology:

Immediate referral indicated if 11, 8:

• eGFR drops below 45 mL/min/1.73 m²
• Persistent or worsening kidney function despite addressing reversible causes
• Development of significant proteinuria (UACR ≥300 mg/g)
• Recurrent episodes of AKI
• Unclear etiology requiring kidney biopsy consideration

Common Pitfalls to Avoid

1. Assuming full recovery means no risk: Even after AKI resolution, patients have increased risk of future CKD and cardiovascular events. Continue surveillance 3.

2. Ignoring eGFR fluctuations: Single measurements can be misleading. Long-term eGFR plotting over ≥3 years provides more accurate assessment of true kidney function trajectory and minimizes the impact of physiologic fluctuations 12.

3. Misinterpreting medication-related changes: A 20-30% eGFR decline with RAAS inhibitors or SGLT2 inhibitors represents hemodynamic adjustment, not kidney injury, and is actually protective long-term 4, 9. However, declines >30% or this acute presentation warrant medication adjustment.

4. Overlooking the potassium-kidney connection: Hypokalemia itself can cause reversible kidney dysfunction. Both hypokalemia and hyperkalemia increase cardiovascular risk and mortality 4, 13.

5. Using creatinine-based eGFR in unstable states: During acute illness, eGFR equations are inaccurate. The recovery pattern is more informative than absolute values 14.

Risk Stratification for Future Events

Based on current eGFR of 90 mL/min/1.73 m² (assuming no proteinuria), this patient falls into low-risk CKD category per KDIGO classification 15. However, the history of AKI elevates baseline risk and necessitates continued monitoring as outlined above.